Maqola mavzusi

Mualliflar

G‘iyozova M.M.

Muassasa

Buхоrо davlat tibbiyot instituti

Annotatsiya

Bugungi kunga qadar tibbiyotning koronavirus infeksiyasidan zarar ko‘rmaydigan birorta tarmog‘i qolmadi, ya’ni SARS-Co I-2 infeksiyasidan zarar ko‘rmagan va patologiyasi bo‘lmagan organlar va tizimlar yo‘q. L shubhasiz. Virusli infektsiyalar bilan, tibbiyot jamiyati tajribasi ilgari ko'rsatganidek, virusologlar va immunologlar shug'ullangan, ammo koronavirus infektsiyasi bilan SARS-CoV-2 tanaga shunchalik chuqur va har tomonlama kirib bordiki, tegishli mutaxassislar yordam bera olmadilar. ushbu yo'nalishda ilmiy tadqiqotlarni o'rganish va olib borish masalalari. Koronavirus infeksiyasi va uning asoratlarini davolashda organizmning immunobiologiyasi jarayonini o‘rganish muhim ahamiyatga ega. Immunobiologiya bo'yicha bilimlarga bo'lgan ehtiyoj virusli, xususan, koronavirus infektsiyasini tashxislash va davolashda yangi tibbiy usullar va texnologiyalarni joriy etish imkoniyati bilan ham belgilanadi. Angiotensin-konverting ferment-2 (ACE2) va TMPRSS2 ning sirt retseptorlarini ifodalovchi SARS-Co\ '-2 infektsiyali hujayralar, virusning faol replikatsiyasini va chiqarilishini rivojlantiradi, piroptoz paydo bo'ladi - hujayralarning molekulyar tuzilishiga zarar, shu jumladan .1 TP, nuklein kislotalar va ASC oligomerlari. Ular qo'shni epitelial hujayralar, endotelial hujayralar va alveolyar makrofaglar tomonidan tan olinadi, bu yallig'lanishga qarshi sitokinlar va kimyokinlar (jumladan, IL-6, IP-10, makrofag yallig'lanish oqsili la (MI Pl a), MIPlp va MCP1) hosil bo'lishiga olib keladi. Ular monotsitlar, makrofaglar va T hujayralarini infektsiya o'chog'iga jalb qilib, keyingi yallig'lanishni rag'batlantiradilar (T hujayralari tomonidan ishlab chiqarilgan IF.\f biriktirilishi bilan), yallig'lanishga qarshi teskari aloqa zanjiri hosil bo'ladi, immun hujayralar to'planadi, yallig'lanishga qarshi. sitokinlar sitokin bo'ronining rivojlanishi bilan ishlab chiqariladi, bu ko'plab organlarning shikastlanishiga olib keladi. Bundan tashqari, SARS-CoV-2 ning faolligi antikorga bog'liq kuchayish (ADE) orqali kuchayadi, bu organlarning, shu jumladan asab tizimi va og'iz bo'shlig'ining shikastlanishini yanada kuchaytiradi. Koronavirus infektsiyasining alomatlari va asoratlarini davolashda immunitetning hujayra, so‘ngra tizimli darajada o‘zgarishini hisobga olish, shu orqali infektsiyalangan organizmni davolashda shart-sharoitlar va ma’lum terapiyani yaratish hamda asoratlar rivojlanishining oldini olish muhim ahamiyatga ega. va COVID-19 dan o'lim.

Kalit so'zlar

immunobiologik komponentlar, koronavirus infeksiyasining klinik kechishi, angiotenzinga aylantiruvchi ferment, ko'p organlar.

Adabiyotlar

1. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/dg/spccchcs/dctail/who-dircctor-gencral-s- openingrcmarks-at-ihc-mcdia-briefing-on-covid-19— 11 -march-2020.
2. Fehr A.R. Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods. Mol. Biol. 2015:1282:1 23.
3. Coronaviridac Study Ciroup of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndromerelated coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 2020;5:536-544.
4. Zhou. P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270 273 (2020).
5. Andersen. K. G.. Ranibaut. A.. Lipkin. W. I., Holmes. E. C. & Garry, R. F. The proximal origin of SARS-CoV-2. Nat. Med. https;/ doi.org/10,1038 s41591 -020-0820-9 (2020).
6. Guan. W. J. ct al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. https://d0i.0rg/l 0.1056/NEJMoa2002032 (2020).
7. Pung. R. et al. Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures. Lancet 395. 1039 1046 (2020).
8. Davlatov. S.. Rakhmanov. K.. Usarov. S., Yuldoshcv, I'.. Xudaynazarov. U., & Tuxtayev, J. (2020). Inguinal hernia: Modern aspects of ctiopathogcncsis and treatment. International Journal of Pharmaceutical Research. 12. 1912-1921. doi: 0.31838/ijpr/2O2O.SP2.338
9. Mukhamadovna G. M. A Modern Approach to the Early Diagnosis and Treatment of Chronic Diseases of the Oral Mucosa //American Journal of Pediatric Medicine and Health Sciences. – 2023. – Т. 1. – №. 3. – С. 119-126. Giyazova Malika Mukhamadovna Features of Morphological Changes in the Mouth Mucosa in Coronavirus Infection
10. Mukhamadovna G. M. Features of Morphological Changes in the Mouth Mucosa in Coronavirus Infection //Scholastic: Journal of Natural and Medical Education. – 2023. – Т. 2. – №. 5. – С. 450-455.
11. Mukhamadovna G. M. The Importance of Using Lysozyme in the Treatment of Changes in the Oral Mucosa of a Patient with Coronavirus //AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI. – 2022. – Т. 1. – №. 7. – С. 214-219.
12. Muxamadovna G. M. OG'IZ BO'SHLIG’I SHILLIQ QAVATINING SURUNKALI KASALLIKLARINI ERTA TASHXISLASH VA DAVOLASHGA ZAMONAVIY YONDASHUV //AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI. – 2023. – Т. 2. – №. 5. – С. 332-340.
13. Гиязова М. М. Изменения Слизистой Полости Рта При Коронавирусной Инфекции //AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI. – 2022. – Т. 1. – №. 7. – С. 301-304.
14. Giyazova Malika Mukhamadovna ETIOPATHOGENETIC ASPECTS AND FEATURES OF DAMAGE TO THE STRUCTURES OF THE ORAL CAVITY IN CORONAVIRUS INFECTION //WEB OF SCIENTIST: INTERNATIONAL SCIENTEFIC RESEARCH JOURNAL.- 2022.- Т. 3. - №. 11.- С. 943-953
15. Giyazova M. M. Effectiveness in the Treatment of Changes in the Oral Mucosa of a Patient with Coronavirus //MIDDLE EUROPEAN SCIENTIFIC BULLETIN ACADEMIC JOURNAL. – 2022. - Т. 28. - С. 55- 59
16. Гиязова М. М., Саноева М. Ж. НЕЙРОСТОМАТОЛОГИЧЕСКИЕ ОСОБЕННОСТИ ПОРАЖЕНИЯ СТРУКТУР ПОЛОСТИ РТА ПРИ КОРОНАВИРУСНОЙ ИНФЕКЦИИ //Conferences. – 2022. – С. 98-110.
17. Giyazova M. M. Modern Treatment of Diseases of the Oral Mucosa and Periodontal Under the Influence of Covid 19 //International Journal on Integrated Education. – 2021. – Т. 4. – №. 10. – С. 96-97.
18. Giyazova M. M. Specificity of the Course and Improvement of Treatment of Diseases of the Oral Mucosa and Periodontal Cavity under the Influence of Covid 19 //" ONLINE-CONFERENCES" PLATFORM. – 2021. – С. 116-117
19. Giyazova M. M., Sh O. S. CHANGES IN THE ORAL CAVITY IN PATIENTS WITH COVID 19 DISEASES //Journal For Innovative Development in Pharmaceutical and Technical Science (JIDPTS). – 2021. – Т. 4. – №. 5. C. 79-81.
20. Muxamadovna G. M. OG'IZ BO'SHLIG’I SHILLIQ QAVATINING SURUNKALI KASALLIKLARINI ERTA TASHXISLASH VA DAVOLASHGA ZAMONAVIY YONDASHUV //AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI. – 2023. – Т. 2. – №. 5. – С. 332-340.
21. Giyazova M. M. Methods of Dental Examination of Patients with Covid 19 //Central Asian Journal of Medical and Natural Science. – 2022. – Т. 3. – №. 3. – С. 522-527.
22. Giyazova M. M. Specificity of the course and improvement of treatment of diseases of the oral mucosa and periodontal cavity under the influence of covid 19//International scientific and рractical online сonference //ACTUAL PROBLEMS PEDIATRIC DENTISTRY. – 2021. – С. 336.
23. Giyazova, M. M. "Structure Of Treatment of Diseases of The Oral Mucosa and Periodontal Under the Influence of Covid 19//Eurasian Scientific Herald." (2021): 37-40.
24. G. M. M. O. S. MODERN ORAL INFECTION IN PATIENTS WITH COVID 19 DISEASES //2nd International Conference on Science Technology and Educational Practices Hosted from Samsun, Turkey http://euroasiaconference. com May 15th-16 th. – 2021. – С. 266-267.
25. Giyazova M. M. The Importance of Using Lysozyme in the Treatment of Changes in the Oral Mucosa of a Patient with Coronavirus //Web of Scholars: Multidimensional Research Journal. – 2022. – Т. 1. – №. 5. – С. 114-119.
26. Giyazova Malika Mukhamadovna ORAL MUCOSA, SALIVA AND COVID-19 INFECTION // Web of Scientist: International Scientific Research Journal. -2022. – T. 1. - №. 6. – С. 1571-1578
27. Giyazova M.M. Modern Diagnostics of the Oral Mucosa in Patients With Covid-19 //MIDDLE EUROPEAN SCIENTIFIC BULLETIN journal. -2022. - 25. - C. 191-199